119 related articles for article (PubMed ID: 36163055)
21. NCAPH is upregulated in endometrial cancer and associated with poor clinicopathologic characteristics.
Qiu X; Gao Z; Shao J; Li H
Ann Hum Genet; 2020 Nov; 84(6):437-446. PubMed ID: 32628282
[TBL] [Abstract][Full Text] [Related]
22. Crabp2 Promotes Metastasis of Lung Cancer Cells via HuR and Integrin β1/FAK/ERK Signaling.
Wu JI; Lin YP; Tseng CW; Chen HJ; Wang LH
Sci Rep; 2019 Jan; 9(1):845. PubMed ID: 30696915
[TBL] [Abstract][Full Text] [Related]
23. LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells.
Lu M; Ding N; Zhuang S; Li Y
Mol Cell Biochem; 2020 Jun; 469(1-2):9-19. PubMed ID: 32314193
[TBL] [Abstract][Full Text] [Related]
24. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
Front Immunol; 2021; 12():805883. PubMed ID: 35095892
[TBL] [Abstract][Full Text] [Related]
25. CRABP2 Is Associated With Thyroid Cancer Recurrence and Promotes Invasion via the Integrin/FAK/AKT Pathway.
Liu CL; Hsu YC; Kuo CY; Jhuang JY; Li YS; Cheng SP
Endocrinology; 2022 Oct; 163(12):. PubMed ID: 36240291
[TBL] [Abstract][Full Text] [Related]
26. CRABP1 and CRABP2 Protein Levels Correlate with Each Other but Do Not Correlate with Sensitivity of Breast Cancer Cells to Retinoic Acid.
Enikeev AD; Komelkov AV; Axelrod ME; Galetsky SA; Kuzmichev SA; Tchevkina EM
Biochemistry (Mosc); 2021 Feb; 86(2):217-229. PubMed ID: 33832420
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of PKN1 as a Prognosis Biomarker for Endometrial Cancer.
Govorov I; Attarha S; Kovalevska L; Andersson E; Kashuba E; Mints M
Cancer Control; 2022; 29():10732748221094797. PubMed ID: 35533253
[TBL] [Abstract][Full Text] [Related]
28. L1CAM is an independent predictor of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA).
Dellinger TH; Smith DD; Ouyang C; Warden CD; Williams JC; Han ES
Gynecol Oncol; 2016 May; 141(2):336-340. PubMed ID: 26861585
[TBL] [Abstract][Full Text] [Related]
29. Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer.
Miao Y; Konno Y; Wang B; Zhu L; Zhai T; Ihira K; Kobayashi N; Watari H; Jin X; Yue J; Dong P; Fang M
J Transl Med; 2023 Feb; 21(1):151. PubMed ID: 36829176
[TBL] [Abstract][Full Text] [Related]
30. Tumor Promoting Effect of BMP Signaling in Endometrial Cancer.
Fukuda T; Fukuda R; Miyazono K; Heldin CH
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360647
[TBL] [Abstract][Full Text] [Related]
31. Establishment of the Prognosis Predicting Signature for Endometrial Cancer Patient.
Tang J; Ma W; Luo L
Med Sci Monit; 2019 Nov; 25():8248-8259. PubMed ID: 31678981
[TBL] [Abstract][Full Text] [Related]
32. BMI‑1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor.
Yu J; Chen L; Bao Z; Liu Y; Liu G; Li F; Li L
Oncol Rep; 2020 May; 43(5):1630-1640. PubMed ID: 32323819
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of Sam68 expression in endometrial carcinoma.
Wang Q; Li Y; Zhou J; Liu J; Qin J; Xing F; Zhang J; Cheng J
Tumour Biol; 2015 Jun; 36(6):4509-18. PubMed ID: 25874492
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of CRABP2 by TET1-mediated DNA hydroxymethylation attenuates mitochondrial apoptosis and promotes oxaliplatin resistance in gastric cancer.
Tang X; Liang Y; Sun G; He Q; Hou Z; Jiang X; Gao P; Qu H
Cell Death Dis; 2022 Oct; 13(10):848. PubMed ID: 36195596
[TBL] [Abstract][Full Text] [Related]
35. Identification and Function Analysis of a Five-Long Noncoding RNA Prognostic Signature for Endometrial Cancer Patients.
Tang H; Wu Z; Zhang Y; Xia T; Liu D; Cai J; Ye Q
DNA Cell Biol; 2019 Dec; 38(12):1480-1498. PubMed ID: 31539276
[TBL] [Abstract][Full Text] [Related]
36. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
He Z; Xu H; Meng Y; Kuang Y
Biomed Pharmacother; 2017 Apr; 88():902-910. PubMed ID: 28178620
[TBL] [Abstract][Full Text] [Related]
37. Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
Li X; Yin F; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
Cancer Med; 2021 Jan; 10(2):693-708. PubMed ID: 33350104
[TBL] [Abstract][Full Text] [Related]
38. Significance of
Chen Y; Zhao W; Bi F; Pan X; Yin L; Zhao C
Oxid Med Cell Longev; 2022; 2022():1817339. PubMed ID: 35847579
[TBL] [Abstract][Full Text] [Related]
39. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway.
Xu Q; Ge Q; Zhou Y; Yang B; Yang Q; Jiang S; Jiang R; Ai Z; Zhang Z; Teng Y
EBioMedicine; 2020 Jan; 51():102609. PubMed ID: 31915116
[TBL] [Abstract][Full Text] [Related]
40. CRABP2 accelerates epithelial mesenchymal transition in serous ovarian cancer cells by promoting TRIM16 methylation via upregulating EZH2 expression.
Xie T; Tan M; Gao Y; Yang H
Environ Toxicol; 2022 Aug; 37(8):1957-1967. PubMed ID: 35442568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
